The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 01, 2025 for Raksha Sudhir Valia
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts more than Nifty 100 and 0.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Raksha Sudhir Valia, a person acting in concert (promoter group member) holding 2,88,30,352 shares (1.20% stake) in Sun Pharma, has disclosed creation of three new pledges covering 14,60,000 equity shares (about 0.06% of total share capital). The pledges were created on March 27-28, 2025, with 4,00,000 and 5,60,000 shares pledged in favor of Aditya Birla Finance Ltd, and 5,00,000 shares pledged in favor of Tata Capital Ltd, all as security for loans availed by a third party. After these events, her total encumbered shares have risen from 99,05,400 to 1,13,65,400 shares, representing 0.47% of Sun Pharma's total share capital. The pledges are for third-party borrowings, not for company-level financing.
The pledges are small in size relative to Sun Pharma's total share capital and are against third-party loans, not company borrowing. Raksha Valia's encumbered shares now stand at about 39% of her personal holding, well below the 50% threshold that typically raises concern. Investors are unlikely to see any material impact on the stock from this disclosure.